APA (7th ed.) Citation

Mehta, D., Davis, M., Epstein, A., Wensel, B., Thach, A., & Williams, G. (2022). EE224 Comparative Economic Outcomes in Patients with Focal Seizure Initiating Eslicarbazepine Acetate Versus Brivaracetam after Switching from Generic Antiseizure Drug. Value in Health, 25(7), S377. https://doi.org/10.1016/j.jval.2022.04.472

Chicago Style (17th ed.) Citation

Mehta, D., M. Davis, AJ Epstein, B. Wensel, A. Thach, and GR Williams. "EE224 Comparative Economic Outcomes in Patients with Focal Seizure Initiating Eslicarbazepine Acetate Versus Brivaracetam After Switching from Generic Antiseizure Drug." Value in Health 25, no. 7 (2022): S377. https://doi.org/10.1016/j.jval.2022.04.472.

MLA (9th ed.) Citation

Mehta, D., et al. "EE224 Comparative Economic Outcomes in Patients with Focal Seizure Initiating Eslicarbazepine Acetate Versus Brivaracetam After Switching from Generic Antiseizure Drug." Value in Health, vol. 25, no. 7, 2022, p. S377, https://doi.org/10.1016/j.jval.2022.04.472.